HPV and HSV Infections – Epidemiology Insights and Forecast (2016-2028)

Chapter 1. Research Background

1.1 Research Objectives

1.2 Definition

1.3 Research Scope

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By industry participant

2.2.1.2 By geography

2.2.2 Key Opinion Leaders (KOLs) Validation

2.3 Coverage of Epidemiology Analysis

2.4 Forecast Methodology

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 HPV

4.1.1 Disease Overview

4.1.2 Transmission of HPV and Risk Factors

4.1.3 Signs and Symptoms

4.1.4 Prevention

4.1.5 Pathophysiology

4.1.6 Diagnosis

4.1.7 Treatment

4.2 HSV

4.2.1 Disease Overview

4.2.2 Causes and Risk Factors

4.2.2.1 HSV-1

4.2.2.2 HSV-2

4.2.3 Prognosis

4.2.4 Signs and Symptoms

4.2.4.1 HSV-1

4.2.4.2 HSV-2

4.2.5 Pathophysiology

4.2.6 Diagnosis

4.2.7 Treatment

4.3 Unmet Medical Needs

4.3.1 Immunization Programs

4.3.2 Proper Diagnosis

4.3.3 Expanded Use of Currently Approved Therapy

4.3.4 Defined Treatment Algorithm

Chapter 5. HPV Infections Epidemiology Forecast for 12MM

5.1 Epidemiology Forecast for 12MM

5.1.1 By Sex

5.2 Epidemiology Forecast for the U.S.

5.2.1 By Sex

5.3 Epidemiology Forecast for EU5

5.3.1 By Sex

5.4 Epidemiology Forecast for Germany

5.4.1 By Sex

5.5 Epidemiology Forecast for France

5.5.1 By Sex

5.6 Epidemiology Forecast for the U.K.

5.6.1 By Sex

5.7 Epidemiology Forecast for Italy

5.7.1 By Sex

5.8 Epidemiology Forecast for Spain

5.8.1 By Sex

5.9 Epidemiology Forecast for Japan

5.9.1 By Sex

5.10 Epidemiology Forecast for India

5.10.1 By Sex

5.11 Epidemiology Forecast for China

5.11.1 By Sex

5.12 Epidemiology Forecast for Russia

5.12.1 By Sex

5.13 Epidemiology Forecast for Indonesia

5.13.1 By Sex

5.14 Epidemiology Forecast for Vietnam

5.14.1 By Sex

Chapter 6. HSV Infections Epidemiology Forecast for 12MM

6.1 Epidemiology Forecast for 12MM

6.1.1 By Sex

6.1.1.1 HSV-1

6.1.1.2 HSV-2

6.2 Epidemiology Forecast for the U.S.

6.2.1 By Sex

6.2.1.1 HSV-1

6.2.1.2 HSV-2

6.3 Epidemiology Forecast for EU5

6.3.1 By Sex

6.3.1.1 HSV-1

6.3.1.2 HSV-2

6.4 Epidemiology Forecast for the U.K.

6.4.1 By Sex

6.4.1.1 HSV-1

6.4.1.2 HSV-2

6.5 Epidemiology Forecast for Spain

6.5.1 By Sex

6.5.1.1 HSV-1

6.5.1.2 HSV-2

6.6 Epidemiology Forecast for Italy

6.6.1 HSV Incident Cases by Sex

6.6.1.1 HSV-1

6.6.1.2 HSV-2

6.7 Epidemiology Forecast for France

6.7.1 By Sex

6.7.1.1 HSV-1

6.7.1.2 HSV-2

6.8 Epidemiology Forecast for Germany

6.8.1 By Sex

6.8.1.1 HSV-1

6.8.1.2 HSV-2

6.9 Epidemiology Forecast for Japan

6.9.1 By Sex

6.9.1.1 HSV-1

6.9.1.2 HSV-2

6.10 Epidemiology Forecast for India

6.10.1 By Sex

6.10.1.1 HSV-1

6.10.1.2 HSV-2

6.11 Epidemiology Forecast for Vietnam

6.11.1 By Sex

6.11.1.1 HSV-1

6.11.1.2 HSV-2

6.12 Epidemiology Forecast for Russia

6.12.1 By Sex

6.12.1.1 HSV-1

6.12.1.2 HSV-2

6.13 Epidemiology Forecast for China

6.13.1 By Sex

6.13.1.1 HSV-1

6.13.1.2 HSV-2

6.14 Epidemiology Forecast for Indonesia

6.14.1 By Sex

6.14.1.1 HSV-1

6.14.1.2 HSV-2

Chapter 7. Appendix

7.1 Abbreviations

7.2 Sources and References

7.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 HPV INFECTIONS EPIDEMIOLOGY IN 12MM (2016–2021)

TABLE 2 HPV INFECTIONS EPIDEMIOLOGY IN 12MM (2022–2028)

TABLE 3 HPV INCIDENT CASES IN 12MM, BY SEX (2016–2021)

TABLE 4 HPV INCIDENT CASES IN 12MM, BY SEX (2022–2028)

TABLE 5 HPV INFECTIONS EPIDEMIOLOGY IN THE U.S. (2016–2021)

TABLE 6 HPV INFECTIONS EPIDEMIOLOGY IN THE U.S. (2022–2028)

TABLE 7 HPV INCIDENT CASES IN THE U.S., BY SEX (2016–2021)

TABLE 8 HPV INCIDENT CASES IN THE U.S., BY SEX (2022–2028)

TABLE 9 HPV INFECTIONS EPIDEMIOLOGY IN EU5 (2016–2021)

TABLE 10 HPV INFECTIONS EPIDEMIOLOGY IN EU5 (2022–2028)

TABLE 11 HPV INCIDENT CASES IN EU5, BY SEX (2016–2021)

TABLE 12 HPV INCIDENT CASES IN EU5, BY SEX (2022–2028)

TABLE 13 HPV INFECTIONS EPIDEMIOLOGY IN GERMANY (2016–2021)

TABLE 14 HPV INFECTIONS EPIDEMIOLOGY IN GERMANY (2022–2028)

TABLE 15 HPV INCIDENT CASES IN GERMANY, BY SEX (2016–2021)

TABLE 16 HPV INCIDENT CASES IN GERMANY, BY SEX (2022–2028)

TABLE 17 HPV INFECTIONS EPIDEMIOLOGY IN FRANCE (2016–2021)

TABLE 18 HPV INFECTIONS EPIDEMIOLOGY IN FRANCE (2022–2028)

TABLE 19 HPV INCIDENT CASES IN FRANCE, BY SEX (2016–2021)

TABLE 20 HPV INCIDENT CASES IN FRANCE, BY SEX (2022–2028)

TABLE 21 HPV INFECTIONS EPIDEMIOLOGY IN THE U.K. (2016–2021)

TABLE 22 HPV INFECTIONS EPIDEMIOLOGY IN THE U.K. (2022-2028)

TABLE 23 HPV INCIDENT CASES IN THE U.K., BY SEX (2016–2021)

TABLE 24 HPV INCIDENT CASES IN THE U.K., BY SEX (2022–2028)

TABLE 25 HPV INFECTIONS EPIDEMIOLOGY IN ITALY (2016–2021)

TABLE 26 HPV INFECTIONS EPIDEMIOLOGY IN ITALY (2022–2028)

TABLE 27 HPV INCIDENT CASES IN ITALY, BY SEX (2016–2021)

TABLE 28 HPV INCIDENT CASES IN ITALY, BY SEX (2022–2028)

TABLE 29 HPV INFECTIONS EPIDEMIOLOGY IN SPAIN (2016–2021)

TABLE 30 HPV INFECTIONS EPIDEMIOLOGY IN SPAIN (2022–2028)

TABLE 31 HPV INCIDENT CASES IN SPAIN, BY SEX (2016–2021)

TABLE 32 HPV INCIDENT CASES IN SPAIN, BY SEX (2022–2028)

TABLE 33 HPV INFECTIONS EPIDEMIOLOGY IN JAPAN (2016–2021)

TABLE 34 HPV INFECTIONS EPIDEMIOLOGY IN JAPAN (2022–2028)

TABLE 35 HPV INCIDENT CASES IN JAPAN, BY SEX (2016–2021)

TABLE 36 HPV INCIDENT CASES IN JAPAN, BY SEX (2022–2028)

TABLE 37 HPV INFECTIONS EPIDEMIOLOGY IN INDIA (2016–2021)

TABLE 38 HPV INFECTIONS EPIDEMIOLOGY IN INDIA (2022–2028)

TABLE 39 HPV INCIDENT CASES IN INDIA, BY SEX (2016–2021)

TABLE 40 HPV INCIDENT CASES IN INDIA, BY SEX (2022–2028)

TABLE 41 HPV INFECTIONS EPIDEMIOLOGY IN CHINA (2016–2021)

TABLE 42 HPV INFECTIONS EPIDEMIOLOGY IN CHINA (2022–2028)

TABLE 43 HPV INCIDENT CASES IN CHINA, BY SEX (2016–2021)

TABLE 44 HPV INCIDENT CASES IN CHINA, BY SEX (2022–2028)

TABLE 45 HPV INFECTIONS EPIDEMIOLOGY IN RUSSIA (2016–2021)

TABLE 46 HPV INFECTIONS EPIDEMIOLOGY IN RUSSIA (2022–2028)

TABLE 47 HPV INCIDENT CASES IN RUSSIA, BY SEX (2016–2021)

TABLE 48 HPV INCIDENT CASES IN RUSSIA, BY SEX (2022–2028)

TABLE 49 HPV INFECTIONS EPIDEMIOLOGY IN INDONESIA (2016–2021)

TABLE 50 HPV INFECTIONS EPIDEMIOLOGY IN INDONESIA (2022–2028)

TABLE 51 HPV INCIDENT CASES IN INDONESIA, BY SEX (2016–2021)

TABLE 52 HPV INCIDENT CASES IN INDONESIA, BY SEX (2022–2028)

TABLE 53 HPV INFECTIONS EPIDEMIOLOGY IN VIETNAM (2016–2021)

TABLE 54 HPV INFECTIONS EPIDEMIOLOGY IN VIETNAM (2022–2028)

TABLE 55 HPV INCIDENT CASES IN VIETNAM, BY SEX (2016–2021)

TABLE 56 HPV INCIDENT CASES IN VIETNAM, BY SEX (2022–2028)

TABLE 57 HSV EPIDEMIOLOGY IN 12MM (2016–2021)

TABLE 58 HSV EPIDEMIOLOGY IN 12MM (2022–2028)

TABLE 59 HSV-1 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2016–2021)

TABLE 60 HSV-1 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2022–2028)

TABLE 61 HSV-2 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2016–2021)

TABLE 62 HSV-2 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2022–2028)

TABLE 63 HSV EPIDEMIOLOGY IN THE U.S. (2016–2021)

TABLE 64 HSV EPIDEMIOLOGY IN THE U.S. (2022–2028)

TABLE 65 HSV-1 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2016–2021)

TABLE 66 HSV-1 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2022–2028)

TABLE 67 HSV-2 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2016–2021)

TABLE 68 HSV-2 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2022–2028)

TABLE 69 HSV EPIDEMIOLOGY IN EU5 (2016–2021)

TABLE 70 HSV EPIDEMIOLOGY IN EU5 (2022–2028)

TABLE 71 HSV-1 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2016–2021)

TABLE 72 HSV-1 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2022–2028)

TABLE 73 HSV-2 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2016–2021)

TABLE 74 HSV-2 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2022–2028)

TABLE 75 HSV EPIDEMIOLOGY IN THE U.K. (2016–2021)

TABLE 76 HSV EPIDEMIOLOGY IN THE U.K. (2022–2028)

TABLE 77 HSV-1 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2016–2021)

TABLE 78 HSV-1 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2022–2028)

TABLE 79 HSV-2 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2016–2021)

TABLE 80 HSV-2 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2022–2028)

TABLE 81 HSV EPIDEMIOLOGY IN SPAIN (2016–2021)

TABLE 82 HSV EPIDEMIOLOGY IN SPAIN (2022–2028)

TABLE 83 HSV-1 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2016–2021)

TABLE 84 HSV-1 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2022–2028)

TABLE 85 HSV-2 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2016–2021)

TABLE 86 HSV-2 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2022–2028)

TABLE 87 HSV EPIDEMIOLOGY IN ITALY (2016–2021)

TABLE 88 HSV EPIDEMIOLOGY IN ITALY (2022–2028)

TABLE 89 HSV-1 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2016–2021)

TABLE 90 HSV-1 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2022–2028)

TABLE 91 HSV-2 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2016–2021)

TABLE 92 HSV-2 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2022–2028)

TABLE 93 HSV EPIDEMIOLOGY IN FRANCE (2016–2021)

TABLE 94 HSV EPIDEMIOLOGY IN FRANCE (2022–2028)

TABLE 95 HSV-1 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2016–2021)

TABLE 96 HSV-1 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2022–2028)

TABLE 97 HSV-2 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2016–2021)

TABLE 98 HSV-2 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2022–2028)

TABLE 99 HSV EPIDEMIOLOGY IN GERMANY (2016–2021)

TABLE 100 HSV EPIDEMIOLOGY IN GERMANY (2022–2028)

TABLE 101 HSV-1 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2016–2021)

TABLE 102 HSV-1 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2022–2028)

TABLE 103 HSV-2 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2016–2021)

TABLE 104 HSV-2 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2022–2028)

TABLE 105 HSV EPIDEMIOLOGY IN JAPAN (2016–2021)

TABLE 106 HSV EPIDEMIOLOGY IN JAPAN (2022–2028)

TABLE 107 HSV-1 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2016–2021)

TABLE 108 HSV-1 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2022–2028)

TABLE 109 HSV-2 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2016–2021)

TABLE 110 HSV-2 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2022–2028)

TABLE 111 HSV EPIDEMIOLOGY IN INDIA (2016–2021)

TABLE 112 HSV EPIDEMIOLOGY IN INDIA (2022–2028)

TABLE 113 HSV-1 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2016–2021)

TABLE 114 HSV-1 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2022–2028)

TABLE 115 HSV-2 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2016–2021)

TABLE 116 HSV-2 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2022–2028)

TABLE 117 HSV EPIDEMIOLOGY IN VIETNAM (2016–2021)

TABLE 118 HSV EPIDEMIOLOGY IN VIETNAM (2022–2028)

TABLE 119 HSV-1 PREVALENT CASES IN VIETNAM, BY SEX, ‘000 (2016–2021)

TABLE 120 HSV-1 PREVALENT CASES IN VIETNAM, BY SEX, ‘000 (2022–2028)

TABLE 121 HSV-2 PREVALENT CASES IN VIETNAM, BY SEX, ‘000 (2016–2021)

TABLE 122 HSV-2 PREVALENT CASES IN VIETNAM, BY SEX, ‘000 (2022–2028)

TABLE 123 HSV EPIDEMIOLOGY IN RUSSIA (2016–2021)

TABLE 124 HSV EPIDEMIOLOGY IN RUSSIA (2022–2028)

TABLE 125 HSV-1 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2016–2021)

TABLE 126 HSV-1 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2022–2028)

TABLE 127 HSV-2 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2016–2021)

TABLE 128 HSV-2 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2022–2028)

TABLE 129 HSV EPIDEMIOLOGY IN CHINA (2016–2021)

TABLE 130 HSV EPIDEMIOLOGY IN CHINA (2022–2028)

TABLE 131 HSV-1 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2016–2021)

TABLE 132 HSV-1 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2022–2028)

TABLE 133 HSV-2 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2016–2021)

TABLE 134 HSV-2 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2022–2028)

TABLE 135 HSV EPIDEMIOLOGY IN INDONESIA (2016–2021)

TABLE 136 HSV EPIDEMIOLOGY IN INDONESIA (2022–2028)

TABLE 137 HSV-1 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2016–2021)

TABLE 138 HSV-1 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2022–2028)

TABLE 139 HSV-2 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2016–2021)

TABLE 140 HSV-2 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2022–2028)

TABLE 141 ABBREVIATIONS

TABLE 142 SOURCES AND REFERENCES

 

LIST OF FIGURES

 

FIG 1 RESEARCH METHODOLOGY

FIG 2 BREAKDOWN OF PRIMARY RESEARCH RESPONDENTS, BY INDUSTRY PARTICIPANT

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY GEOGRAPHY

FIG 4 HPV INFECTIONS EPIDIEMOLOGY SUMMARY

FIG 5 HSV INFECTIONS EPIDIEMOLOGY SUMMARY

FIG 6 HPV AND HSV INFECTIONS – UNMET MEDICAL NEEDS

FIG 7 NUMBER OF INCIDENT CASES FOR HPV IN 12MM (2016 & 2028)

FIG 8 HPV INCIDENT CASES IN 12MM, BY SEX (2016-2028)

FIG 9 HPV INFECTIONS EPIDEMIOLOGY IN THE U.S. (2016–2028)

FIG 10 HPV INCIDENT CASES IN U.S., BY SEX (2016-2028)

FIG 11 HPV INFECTIONS EPIDEMIOLOGY IN EU5 (2016–2028)

FIG 12 HPV INCIDENT CASES IN EU5, BY SEX (2016-2028)

FIG 13 HPV INFECTIONS EPIDEMIOLOGY IN GERMANY (2016–2028)

FIG 14 HPV INCIDENT CASES IN GERMANY, BY SEX (2016–2028)

FIG 15 HPV INFECTIONS EPIDEMIOLOGY IN FRANCE (2016–2028)

FIG 16 HPV INCIDENT CASES IN FRANCE, BY SEX (2016–2028)

FIG 17 HPV INFECTIONS EPIDEMIOLOGY IN THE U.K. (2016–2028)

FIG 18 HPV INCIDENT CASES IN THE U.K., BY SEX (2016–2028)

FIG 19 HPV INFECTIONS EPIDEMIOLOGY IN ITALY (2016–2028)

FIG 20 HPV INCIDENT CASES IN ITALY, BY SEX (2016–2028)

FIG 21 HPV INFECTIONS EPIDEMIOLOGY IN SPAIN (2016–2028)

FIG 22 HPV INCIDENT CASES IN SPAIN, BY SEX (2016–2028)

FIG 23 HPV INFECTIONS EPIDEMIOLOGY IN JAPAN (2016–2028)

FIG 24 HPV INCIDENT CASES IN JAPAN, BY SEX (2016–2028)

FIG 25 HPV INFECTIONS EPIDEMIOLOGY IN INDIA (2016-2028)

FIG 26 HPV INCIDENT CASES IN INDIA, BY SEX (2016–2028)

FIG 27 HPV INFECTIONS EPIDEMIOLOGY IN CHINA (2016–2028)

FIG 28 HPV INCIDENT CASES IN CHINA, BY SEX (2016–2028)

FIG 29 HPV INFECTIONS EPIDEMIOLOGY IN RUSSIA (2016–2028)

FIG 30 HPV INCIDENT CASES IN RUSSIA, BY SEX (2016–2028)

FIG 31 HPV INFECTIONS EPIDEMIOLOGY IN INDONESIA (2016–2028)

FIG 32 HPV INCIDENT CASES IN INDONESIA, BY SEX (2016–2028)

FIG 33 HPV INFECTIONS EPIDEMIOLOGY IN VIETNAM (2016–2028)

FIG 34 HPV INCIDENT CASES IN VIETNAM, BY SEX (2016–2028)

FIG 35 NUMBER OF PREVALENT CASES FOR HSV-1 IN 12MM, IN MILLION (2016 & 2028)

FIG 36 NUMBER OF PREVALENT CASES FOR HSV-2 IN 12MM, IN MILLION (2016 & 2028)

FIG 37 HSV-1 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2016–2028)

FIG 38 HSV-2 PREVALENT CASES IN 12MM, BY SEX, IN MILLION (2016–2028)

FIG 39 NUMBER OF HSV-1 PREVALENT CASES IN THE U.S. (2016–2028)

FIG 40 NUMBER OF HSV-2 PREVALENT CASES IN THE U.S. (2016–2028)

FIG 41 HSV-1 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2016-2028)

FIG 42 HSV-2 PREVALENT CASES IN THE U.S., BY SEX, ‘000 (2016–2028)

FIG 43 NUMBER OF HSV-1 PREVALENT CASES IN EU5 (2016–2028)

FIG 44 NUMBER OF HSV-2 PREVALENT CASES IN EU5 (2016–2028)

FIG 45 HSV-1 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2016–2028)

FIG 46 HSV-2 PREVALENT CASES IN EU5, BY SEX, IN MILLION (2016–2028)

FIG 47 NUMBER OF HSV-1 PREVALENT CASES IN THE U.K. (2016–2028)

FIG 48 NUMBER OF HSV-2 PREVALENT CASES IN THE U.K. (2016–2028)

FIG 49 HSV-1 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2016–2028)

FIG 50 HSV-2 PREVALENT CASES IN THE U.K., BY SEX, ‘000 (2016–2028)

FIG 51 NUMBER OF HSV-1 PREVALENT CASES IN SPAIN (2016–2028)

FIG 52 NUMBER OF HSV-2 PREVALENT CASES IN SPAIN (2016–2028)

FIG 53 HSV-1 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2016-2028)

FIG 54 HSV-2 PREVALENT CASES IN SPAIN, BY SEX, ‘000 (2016–2028)

FIG 55 NUMBER OF HSV-1 PREVALENT CASES IN ITALY (2016–2028)

FIG 56 NUMBER OF HSV-2 PREVALENT CASES IN ITALY (2016–2028)

FIG 57 HSV-1 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2016–2028)

FIG 58 HSV-2 PREVALENT CASES IN ITALY, BY SEX, ‘000 (2016–2028)

FIG 59 NUMBER OF HSV-1 PREVALENT CASES IN FRANCE (2016–2028)

FIG 60 NUMBER OF HSV-2 PREVALENT CASES IN FRANCE (2016–2028)

FIG 61 HSV-1 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2016–2028)

FIG 62 HSV-2 PREVALENT CASES IN FRANCE, BY SEX, ‘000 (2016–2028)

FIG 63 NUMBER OF HSV-1 PREVALENT CASES IN GERMANY (2016–2028)

FIG 64 NUMBER OF HSV-2 PREVALENT CASES IN GERMANY (2016–2028)

FIG 65 HSV-1 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2016–2028)

FIG 66 HSV-2 PREVALENT CASES IN GERMANY, BY SEX, ‘000 (2016–2028)

FIG 67 NUMBER OF HSV-1 PREVALENT CASES IN JAPAN (2016–2028)

FIG 68 NUMBER OF HSV-2 PREVALENT CASES IN JAPAN (2016–2028)

FIG 69 HSV-1 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2016–2028)

FIG 70 HSV-2 PREVALENT CASES IN JAPAN, BY SEX, ‘000 (2016–2028)

FIG 71 NUMBER OF HSV-1 PREVALENT CASES IN INDIA (2016–2028)

FIG 72 NUMBER OF HSV-2 PREVALENT CASES IN INDIA (2016–2028)

FIG 73 HSV-1 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2016–2028)

FIG 74 HSV-2 PREVALENT CASES IN INDIA, BY SEX, ‘000 (2016–2028)

FIG 75 NUMBER OF HSV-1 PREVALENT CASES IN VIETNAM (2016–2028)

FIG 76 NUMBER OF HSV-2 PREVALENT CASES IN VIETNAM (2016–2028)

FIG 77 HSV-1 PREVALENT CASES IN VIETNAM, BY SEX (2016–2028)

FIG 78 HSV-2 PREVALENT CASES IN VIETNAM, BY SEX, ‘000 (2016–2028)

FIG 79 NUMBER OF HSV-1 PREVALENT CASES IN RUSSIA (2016–2028)

FIG 80 NUMBER OF HSV-2 PREVALENT CASES IN RUSSIA (2016–2028)

FIG 81 HSV-1 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2016–2028)

FIG 82 HSV-2 PREVALENT CASES IN RUSSIA, BY SEX, ‘000 (2016–2028)

FIG 83 NUMBER OF HSV-1 PREVALENT CASES IN CHINA (2016–2028)

FIG 84 NUMBER OF HSV-2 PREVALENT CASES IN CHINA (2016–2028)

FIG 85 HSV-1 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2016–2028)

FIG 86 HSV-2 PREVALENT CASES IN CHINA, BY SEX, ‘000 (2016–2028)

FIG 87 NUMBER OF HSV-1 PREVALENT CASES IN INDONESIA (2016–2028)

FIG 88 NUMBER OF HSV-2 PREVALENT CASES IN INDONESIA (2016–2028)

FIG 89 HSV-1 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2016–2028)

FIG 90 HSV-2 PREVALENT CASES IN INDONESIA, BY SEX, ‘000 (2016–2028)